NO321512B1 - Fremgangsmate for a merke overflaten av faste raskt opplosende doseringsformer og faste raskt opplosende doseringsformer fremstilt ifolge fremgangsmaten - Google Patents

Fremgangsmate for a merke overflaten av faste raskt opplosende doseringsformer og faste raskt opplosende doseringsformer fremstilt ifolge fremgangsmaten Download PDF

Info

Publication number: NO321512B1
Authority: NO; Norway
Prior art keywords: dosage form; dosage forms; solid; characters; gelatin
Prior art date: 1996-06-17

Application number

NO19985877A

Other languages

English (en)

Norwegian (no)

Other versions

NO985877D0 (no

NO985877L (no

Inventor

Gary W Posage

Original Assignee

Janssen Pharmaceutica Nv

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1996-06-17

Filing date

1998-12-15

Publication date

2006-05-15

1998-12-15 Application filed by Janssen Pharmaceutica Nv filed Critical Janssen Pharmaceutica Nv

1998-12-15 Publication of NO985877D0 publication Critical patent/NO985877D0/no

1999-02-16 Publication of NO985877L publication Critical patent/NO985877L/no

2006-05-15 Publication of NO321512B1 publication Critical patent/NO321512B1/no

Links

239000002552 dosage form Substances 0.000 title claims abstract description 78
238000000034 method Methods 0.000 title claims abstract description 58
239000007787 solid Substances 0.000 title claims abstract description 36
238000007641 inkjet printing Methods 0.000 claims abstract description 7
239000000463 material Substances 0.000 claims description 41
239000004480 active ingredient Substances 0.000 claims description 31
239000000203 mixture Substances 0.000 claims description 27
239000002904 solvent Substances 0.000 claims description 23
108010010803 Gelatin Proteins 0.000 claims description 14
229920000159 gelatin Polymers 0.000 claims description 14
235000019322 gelatine Nutrition 0.000 claims description 14
235000011852 gelatine desserts Nutrition 0.000 claims description 14
239000011159 matrix material Substances 0.000 claims description 14
239000008273 gelatin Substances 0.000 claims description 13
DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 claims description 12
238000004108 freeze drying Methods 0.000 claims description 12
XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 12
239000003814 drug Substances 0.000 claims description 11
-1 cyclic oligosaccharide Chemical class 0.000 claims description 10
239000003795 chemical substances by application Substances 0.000 claims description 9
239000007788 liquid Substances 0.000 claims description 8
229940024606 amino acid Drugs 0.000 claims description 7
150000001413 amino acids Chemical class 0.000 claims description 7
238000004090 dissolution Methods 0.000 claims description 7
239000004471 Glycine Substances 0.000 claims description 6
150000004676 glycans Chemical class 0.000 claims description 6
229920001282 polysaccharide Polymers 0.000 claims description 6
239000005017 polysaccharide Substances 0.000 claims description 6
235000018102 proteins Nutrition 0.000 claims description 6
108090000623 proteins and genes Proteins 0.000 claims description 6
102000004169 proteins and genes Human genes 0.000 claims description 6
FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 claims description 5
229930195725 Mannitol Natural products 0.000 claims description 5
238000004049 embossing Methods 0.000 claims description 5
239000000594 mannitol Substances 0.000 claims description 5
235000010355 mannitol Nutrition 0.000 claims description 5
239000000126 substance Substances 0.000 claims description 5
229920002307 Dextran Polymers 0.000 claims description 4
229920001353 Dextrin Polymers 0.000 claims description 4
239000004375 Dextrin Substances 0.000 claims description 4
WHUUTDBJXJRKMK-VKHMYHEASA-N L-glutamic acid Chemical compound OC(=O)[C@@H](N)CCC(O)=O WHUUTDBJXJRKMK-VKHMYHEASA-N 0.000 claims description 4
FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 claims description 4
241000209140 Triticum Species 0.000 claims description 4
235000021307 Triticum Nutrition 0.000 claims description 4
235000019425 dextrin Nutrition 0.000 claims description 4
235000013312 flour Nutrition 0.000 claims description 4
239000012530 fluid Substances 0.000 claims description 4
239000000499 gel Substances 0.000 claims description 4
229920000858 Cyclodextrin Polymers 0.000 claims description 3
239000001814 pectin Substances 0.000 claims description 3
229920001277 pectin Polymers 0.000 claims description 3
235000010987 pectin Nutrition 0.000 claims description 3
229920001059 synthetic polymer Polymers 0.000 claims description 3
230000008016 vaporization Effects 0.000 claims description 3
229920001285 xanthan gum Polymers 0.000 claims description 3
235000010493 xanthan gum Nutrition 0.000 claims description 3
239000000230 xanthan gum Substances 0.000 claims description 3
229940082509 xanthan gum Drugs 0.000 claims description 3
HDTRYLNUVZCQOY-UHFFFAOYSA-N α-D-glucopyranosyl-α-D-glucopyranoside Natural products OC1C(O)C(O)C(CO)OC1OC1C(O)C(O)C(O)C(CO)O1 HDTRYLNUVZCQOY-UHFFFAOYSA-N 0.000 claims description 2
IIZPXYDJLKNOIY-JXPKJXOSSA-N 1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCC\C=C/C\C=C/C\C=C/C\C=C/CCCCC IIZPXYDJLKNOIY-JXPKJXOSSA-N 0.000 claims description 2
OWEGMIWEEQEYGQ-UHFFFAOYSA-N 100676-05-9 Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC2C(OC(O)C(O)C2O)CO)O1 OWEGMIWEEQEYGQ-UHFFFAOYSA-N 0.000 claims description 2
229920001817 Agar Polymers 0.000 claims description 2
102000009027 Albumins Human genes 0.000 claims description 2
108010088751 Albumins Proteins 0.000 claims description 2
GUBGYTABKSRVRQ-XLOQQCSPSA-N Alpha-Lactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 claims description 2
229920001661 Chitosan Polymers 0.000 claims description 2
244000303965 Cyamopsis psoralioides Species 0.000 claims description 2
FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 claims description 2
CKLJMWTZIZZHCS-UHFFFAOYSA-N D-OH-Asp Natural products OC(=O)C(N)CC(O)=O CKLJMWTZIZZHCS-UHFFFAOYSA-N 0.000 claims description 2
FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 claims description 2
239000001116 FEMA 4028 Substances 0.000 claims description 2
101710145505 Fiber protein Proteins 0.000 claims description 2
239000005715 Fructose Substances 0.000 claims description 2
229930091371 Fructose Natural products 0.000 claims description 2
RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 claims description 2
WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 claims description 2
108010068370 Glutens Proteins 0.000 claims description 2
239000004354 Hydroxyethyl cellulose Substances 0.000 claims description 2
229920000663 Hydroxyethyl cellulose Polymers 0.000 claims description 2
PMMYEEVYMWASQN-DMTCNVIQSA-N Hydroxyproline Chemical compound O[C@H]1CN[C@H](C(O)=O)C1 PMMYEEVYMWASQN-DMTCNVIQSA-N 0.000 claims description 2
CKLJMWTZIZZHCS-UWTATZPHSA-N L-Aspartic acid Natural products OC(=O)[C@H](N)CC(O)=O CKLJMWTZIZZHCS-UWTATZPHSA-N 0.000 claims description 2
CKLJMWTZIZZHCS-REOHCLBHSA-N L-aspartic acid Chemical compound OC(=O)[C@@H](N)CC(O)=O CKLJMWTZIZZHCS-REOHCLBHSA-N 0.000 claims description 2
AGPKZVBTJJNPAG-WHFBIAKZSA-N L-isoleucine Chemical compound CC[C@H](C)[C@H](N)C(O)=O AGPKZVBTJJNPAG-WHFBIAKZSA-N 0.000 claims description 2
229930182844 L-isoleucine Natural products 0.000 claims description 2
GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 claims description 2
240000007472 Leucaena leucocephala Species 0.000 claims description 2
235000010643 Leucaena leucocephala Nutrition 0.000 claims description 2
229920000161 Locust bean gum Polymers 0.000 claims description 2
229920002774 Maltodextrin Polymers 0.000 claims description 2
GUBGYTABKSRVRQ-PICCSMPSSA-N Maltose Natural products O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@@H](CO)OC(O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-PICCSMPSSA-N 0.000 claims description 2
229920000168 Microcrystalline cellulose Polymers 0.000 claims description 2
240000007594 Oryza sativa Species 0.000 claims description 2
235000007164 Oryza sativa Nutrition 0.000 claims description 2
108090000526 Papain Proteins 0.000 claims description 2
229920002230 Pectic acid Polymers 0.000 claims description 2
244000090599 Plantago psyllium Species 0.000 claims description 2
235000010451 Plantago psyllium Nutrition 0.000 claims description 2
239000004365 Protease Substances 0.000 claims description 2
244000061456 Solanum tuberosum Species 0.000 claims description 2
235000002595 Solanum tuberosum Nutrition 0.000 claims description 2
CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 claims description 2
229930006000 Sucrose Natural products 0.000 claims description 2
229920001615 Tragacanth Polymers 0.000 claims description 2
HDTRYLNUVZCQOY-WSWWMNSNSA-N Trehalose Natural products O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@@H](CO)O1 HDTRYLNUVZCQOY-WSWWMNSNSA-N 0.000 claims description 2
TVXBFESIOXBWNM-UHFFFAOYSA-N Xylitol Natural products OCCC(O)C(O)C(O)CCO TVXBFESIOXBWNM-UHFFFAOYSA-N 0.000 claims description 2
240000008042 Zea mays Species 0.000 claims description 2
235000005824 Zea mays ssp. parviglumis Nutrition 0.000 claims description 2
235000002017 Zea mays subsp mays Nutrition 0.000 claims description 2
DPXJVFZANSGRMM-UHFFFAOYSA-N acetic acid;2,3,4,5,6-pentahydroxyhexanal;sodium Chemical compound [Na].CC(O)=O.OCC(O)C(O)C(O)C(O)C=O DPXJVFZANSGRMM-UHFFFAOYSA-N 0.000 claims description 2
239000002253 acid Substances 0.000 claims description 2
239000008272 agar Substances 0.000 claims description 2
235000010419 agar Nutrition 0.000 claims description 2
235000010443 alginic acid Nutrition 0.000 claims description 2
229920000615 alginic acid Polymers 0.000 claims description 2
HDTRYLNUVZCQOY-LIZSDCNHSA-N alpha,alpha-trehalose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 HDTRYLNUVZCQOY-LIZSDCNHSA-N 0.000 claims description 2
WQZGKKKJIJFFOK-PHYPRBDBSA-N alpha-D-galactose Chemical compound OC[C@H]1O[C@H](O)[C@H](O)[C@@H](O)[C@H]1O WQZGKKKJIJFFOK-PHYPRBDBSA-N 0.000 claims description 2
239000003963 antioxidant agent Substances 0.000 claims description 2
229960005261 aspartic acid Drugs 0.000 claims description 2
239000000305 astragalus gummifer gum Substances 0.000 claims description 2
WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 claims description 2
WHGYBXFWUBPSRW-FOUAGVGXSA-N beta-cyclodextrin Chemical compound OC[C@H]([C@H]([C@@H]([C@H]1O)O)O[C@H]2O[C@@H]([C@@H](O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O3)[C@H](O)[C@H]2O)CO)O[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@@H]3O[C@@H]1CO WHGYBXFWUBPSRW-FOUAGVGXSA-N 0.000 claims description 2
235000011175 beta-cyclodextrine Nutrition 0.000 claims description 2
GUBGYTABKSRVRQ-QUYVBRFLSA-N beta-maltose Chemical compound OC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O)[C@H](O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@@H]1O GUBGYTABKSRVRQ-QUYVBRFLSA-N 0.000 claims description 2
229960004853 betadex Drugs 0.000 claims description 2
235000013532 brandy Nutrition 0.000 claims description 2
239000001768 carboxy methyl cellulose Substances 0.000 claims description 2
235000005822 corn Nutrition 0.000 claims description 2
239000008121 dextrose Substances 0.000 claims description 2
GXGAKHNRMVGRPK-UHFFFAOYSA-N dimagnesium;dioxido-bis[[oxido(oxo)silyl]oxy]silane Chemical compound [Mg+2].[Mg+2].[O-][Si](=O)O[Si]([O-])([O-])O[Si]([O-])=O GXGAKHNRMVGRPK-UHFFFAOYSA-N 0.000 claims description 2
239000000975 dye Substances 0.000 claims description 2
239000008344 egg yolk phospholipid Substances 0.000 claims description 2
239000003623 enhancer Substances 0.000 claims description 2
235000003599 food sweetener Nutrition 0.000 claims description 2
229930182830 galactose Natural products 0.000 claims description 2
229960002989 glutamic acid Drugs 0.000 claims description 2
235000021312 gluten Nutrition 0.000 claims description 2
229960002449 glycine Drugs 0.000 claims description 2
235000019447 hydroxyethyl cellulose Nutrition 0.000 claims description 2
229910052500 inorganic mineral Inorganic materials 0.000 claims description 2
229960000310 isoleucine Drugs 0.000 claims description 2
239000008101 lactose Substances 0.000 claims description 2
235000010445 lecithin Nutrition 0.000 claims description 2
239000000787 lecithin Substances 0.000 claims description 2
229940067606 lecithin Drugs 0.000 claims description 2
235000010420 locust bean gum Nutrition 0.000 claims description 2
239000000711 locust bean gum Substances 0.000 claims description 2
239000000391 magnesium silicate Substances 0.000 claims description 2
229940099273 magnesium trisilicate Drugs 0.000 claims description 2
229910000386 magnesium trisilicate Inorganic materials 0.000 claims description 2
235000019793 magnesium trisilicate Nutrition 0.000 claims description 2
HEBKCHPVOIAQTA-UHFFFAOYSA-N meso ribitol Natural products OCC(O)C(O)C(O)CO HEBKCHPVOIAQTA-UHFFFAOYSA-N 0.000 claims description 2
229940016286 microcrystalline cellulose Drugs 0.000 claims description 2
235000019813 microcrystalline cellulose Nutrition 0.000 claims description 2
239000008108 microcrystalline cellulose Substances 0.000 claims description 2
239000011707 mineral Substances 0.000 claims description 2
150000002772 monosaccharides Chemical class 0.000 claims description 2
235000015097 nutrients Nutrition 0.000 claims description 2
229920001542 oligosaccharide Polymers 0.000 claims description 2
229940055729 papain Drugs 0.000 claims description 2
235000019834 papain Nutrition 0.000 claims description 2
150000003904 phospholipids Chemical class 0.000 claims description 2
239000010318 polygalacturonic acid Substances 0.000 claims description 2
229920001184 polypeptide Polymers 0.000 claims description 2
239000001267 polyvinylpyrrolidone Substances 0.000 claims description 2
229920000036 polyvinylpyrrolidone Polymers 0.000 claims description 2
235000013855 polyvinylpyrrolidone Nutrition 0.000 claims description 2
239000003755 preservative agent Substances 0.000 claims description 2
102000004196 processed proteins & peptides Human genes 0.000 claims description 2
108090000765 processed proteins & peptides Proteins 0.000 claims description 2
235000009566 rice Nutrition 0.000 claims description 2
235000019812 sodium carboxymethyl cellulose Nutrition 0.000 claims description 2
229920001027 sodium carboxymethylcellulose Polymers 0.000 claims description 2
239000011780 sodium chloride Substances 0.000 claims description 2
239000001488 sodium phosphate Substances 0.000 claims description 2
229910000162 sodium phosphate Inorganic materials 0.000 claims description 2
239000008109 sodium starch glycolate Substances 0.000 claims description 2
229920003109 sodium starch glycolate Polymers 0.000 claims description 2
229940079832 sodium starch glycolate Drugs 0.000 claims description 2
239000000600 sorbitol Substances 0.000 claims description 2
235000010356 sorbitol Nutrition 0.000 claims description 2
239000005720 sucrose Substances 0.000 claims description 2
235000000346 sugar Nutrition 0.000 claims description 2
239000004094 surface-active agent Substances 0.000 claims description 2
239000003765 sweetening agent Substances 0.000 claims description 2
239000006188 syrup Substances 0.000 claims description 2
235000020357 syrup Nutrition 0.000 claims description 2
FGMPLJWBKKVCDB-UHFFFAOYSA-N trans-L-hydroxy-proline Natural products ON1CCCC1C(O)=O FGMPLJWBKKVCDB-UHFFFAOYSA-N 0.000 claims description 2
ODLHGICHYURWBS-LKONHMLTSA-N trappsol cyclo Chemical compound CC(O)COC[C@H]([C@H]([C@@H]([C@H]1O)O)O[C@H]2O[C@@H]([C@@H](O[C@H]3O[C@H](COCC(C)O)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](COCC(C)O)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](COCC(C)O)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](COCC(C)O)[C@H]([C@@H]([C@H]3O)O)O3)[C@H](O)[C@H]2O)COCC(O)C)O[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@@H]3O[C@@H]1COCC(C)O ODLHGICHYURWBS-LKONHMLTSA-N 0.000 claims description 2
RYFMWSXOAZQYPI-UHFFFAOYSA-K trisodium phosphate Chemical compound [Na+].[Na+].[Na+].[O-]P([O-])([O-])=O RYFMWSXOAZQYPI-UHFFFAOYSA-K 0.000 claims description 2
235000013343 vitamin Nutrition 0.000 claims description 2
239000011782 vitamin Substances 0.000 claims description 2
229940088594 vitamin Drugs 0.000 claims description 2
229930003231 vitamin Natural products 0.000 claims description 2
239000000811 xylitol Substances 0.000 claims description 2
235000010447 xylitol Nutrition 0.000 claims description 2
HEBKCHPVOIAQTA-SCDXWVJYSA-N xylitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)CO HEBKCHPVOIAQTA-SCDXWVJYSA-N 0.000 claims description 2
229960002675 xylitol Drugs 0.000 claims description 2
COLNVLDHVKWLRT-QMMMGPOBSA-N L-phenylalanine Chemical compound OC(=O)[C@@H](N)CC1=CC=CC=C1 COLNVLDHVKWLRT-QMMMGPOBSA-N 0.000 claims 2
241000238631 Hexapoda Species 0.000 claims 1
SNAAJJQQZSMGQD-UHFFFAOYSA-N aluminum magnesium Chemical compound [Mg].[Al] SNAAJJQQZSMGQD-UHFFFAOYSA-N 0.000 claims 1
229920001525 carrageenan Polymers 0.000 claims 1
235000010418 carrageenan Nutrition 0.000 claims 1
239000004927 clay Substances 0.000 claims 1
125000004122 cyclic group Chemical group 0.000 claims 1
FZWBNHMXJMCXLU-BLAUPYHCSA-N isomaltotriose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1OC[C@@H]1[C@@H](O)[C@H](O)[C@@H](O)[C@@H](OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C=O)O1 FZWBNHMXJMCXLU-BLAUPYHCSA-N 0.000 claims 1
229960005190 phenylalanine Drugs 0.000 claims 1
239000007909 solid dosage form Substances 0.000 description 18
239000003826 tablet Substances 0.000 description 11
229940079593 drug Drugs 0.000 description 9
239000000976 ink Substances 0.000 description 9
IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 8
239000000725 suspension Substances 0.000 description 8
238000007710 freezing Methods 0.000 description 6
230000008014 freezing Effects 0.000 description 6
CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 description 5
LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 5
239000006185 dispersion Substances 0.000 description 4
238000005187 foaming Methods 0.000 description 4
229910052757 nitrogen Inorganic materials 0.000 description 4
239000004800 polyvinyl chloride Substances 0.000 description 4
229920000915 polyvinyl chloride Polymers 0.000 description 4
239000000523 sample Substances 0.000 description 4
229920002125 Sokalan® Polymers 0.000 description 3
239000002775 capsule Substances 0.000 description 3
238000011049 filling Methods 0.000 description 3
238000002360 preparation method Methods 0.000 description 3
238000000859 sublimation Methods 0.000 description 3
230000008022 sublimation Effects 0.000 description 3
RZVAJINKPMORJF-UHFFFAOYSA-N Acetaminophen Chemical compound CC(=O)NC1=CC=C(O)C=C1 RZVAJINKPMORJF-UHFFFAOYSA-N 0.000 description 2
ROHFNLRQFUQHCH-YFKPBYRVSA-N L-leucine Chemical compound CC(C)C[C@H](N)C(O)=O ROHFNLRQFUQHCH-YFKPBYRVSA-N 0.000 description 2
239000004743 Polypropylene Substances 0.000 description 2
229920001328 Polyvinylidene chloride Polymers 0.000 description 2
JNDMLEXHDPKVFC-UHFFFAOYSA-N aluminum;oxygen(2-);yttrium(3+) Chemical compound [O-2].[O-2].[O-2].[Al+3].[Y+3] JNDMLEXHDPKVFC-UHFFFAOYSA-N 0.000 description 2
239000012736 aqueous medium Substances 0.000 description 2
239000001569 carbon dioxide Substances 0.000 description 2
229910002092 carbon dioxide Inorganic materials 0.000 description 2
239000011248 coating agent Substances 0.000 description 2
239000003086 colorant Substances 0.000 description 2
238000011978 dissolution method Methods 0.000 description 2
238000005530 etching Methods 0.000 description 2
239000006260 foam Substances 0.000 description 2
230000002209 hydrophobic effect Effects 0.000 description 2
239000004615 ingredient Substances 0.000 description 2
238000002372 labelling Methods 0.000 description 2
238000004519 manufacturing process Methods 0.000 description 2
239000012907 medicinal substance Substances 0.000 description 2
229910052751 metal Inorganic materials 0.000 description 2
239000002184 metal Substances 0.000 description 2
229940068196 placebo Drugs 0.000 description 2
239000000902 placebo Substances 0.000 description 2
229920001155 polypropylene Polymers 0.000 description 2
239000005033 polyvinylidene chloride Substances 0.000 description 2
235000021251 pulses Nutrition 0.000 description 2
239000003351 stiffener Substances 0.000 description 2
230000009747 swallowing Effects 0.000 description 2
230000000699 topical effect Effects 0.000 description 2
229910019901 yttrium aluminum garnet Inorganic materials 0.000 description 2
QDGAVODICPCDMU-UHFFFAOYSA-N 2-amino-3-[3-[bis(2-chloroethyl)amino]phenyl]propanoic acid Chemical compound OC(=O)C(N)CC1=CC=CC(N(CCCl)CCCl)=C1 QDGAVODICPCDMU-UHFFFAOYSA-N 0.000 description 1
DBAKFASWICGISY-BTJKTKAUSA-N Chlorpheniramine maleate Chemical compound OC(=O)\C=C/C(O)=O.C=1C=CC=NC=1C(CCN(C)C)C1=CC=C(Cl)C=C1 DBAKFASWICGISY-BTJKTKAUSA-N 0.000 description 1
QNAYBMKLOCPYGJ-UHFFFAOYSA-N D-alpha-Ala Natural products CC([NH3+])C([O-])=O QNAYBMKLOCPYGJ-UHFFFAOYSA-N 0.000 description 1
241000282412 Homo Species 0.000 description 1
HEFNNWSXXWATRW-UHFFFAOYSA-N Ibuprofen Chemical compound CC(C)CC1=CC=C(C(C)C(O)=O)C=C1 HEFNNWSXXWATRW-UHFFFAOYSA-N 0.000 description 1
QNAYBMKLOCPYGJ-UWTATZPHSA-N L-Alanine Natural products C[C@@H](N)C(O)=O QNAYBMKLOCPYGJ-UWTATZPHSA-N 0.000 description 1
QNAYBMKLOCPYGJ-REOHCLBHSA-N L-alanine Chemical compound C[C@H](N)C(O)=O QNAYBMKLOCPYGJ-REOHCLBHSA-N 0.000 description 1
239000004395 L-leucine Substances 0.000 description 1
235000019454 L-leucine Nutrition 0.000 description 1
MKXZASYAUGDDCJ-SZMVWBNQSA-N LSM-2525 Chemical compound C1CCC[C@H]2[C@@]3([H])N(C)CC[C@]21C1=CC(OC)=CC=C1C3 MKXZASYAUGDDCJ-SZMVWBNQSA-N 0.000 description 1
241001465754 Metazoa Species 0.000 description 1
239000004698 Polyethylene Substances 0.000 description 1
239000008186 active pharmaceutical agent Substances 0.000 description 1
239000013543 active substance Substances 0.000 description 1
229960003767 alanine Drugs 0.000 description 1
229910052782 aluminium Inorganic materials 0.000 description 1
XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 description 1
238000004458 analytical method Methods 0.000 description 1
239000012867 bioactive agent Substances 0.000 description 1
239000012472 biological sample Substances 0.000 description 1
239000008280 blood Substances 0.000 description 1
210000004369 blood Anatomy 0.000 description 1
125000004432 carbon atom Chemical group C* 0.000 description 1
235000011089 carbon dioxide Nutrition 0.000 description 1
239000012876 carrier material Substances 0.000 description 1
239000003153 chemical reaction reagent Substances 0.000 description 1
229940046978 chlorpheniramine maleate Drugs 0.000 description 1
DCSUBABJRXZOMT-IRLDBZIGSA-N cisapride Chemical compound C([C@@H]([C@@H](CC1)NC(=O)C=2C(=CC(N)=C(Cl)C=2)OC)OC)N1CCCOC1=CC=C(F)C=C1 DCSUBABJRXZOMT-IRLDBZIGSA-N 0.000 description 1
229960005132 cisapride Drugs 0.000 description 1
DCSUBABJRXZOMT-UHFFFAOYSA-N cisapride Natural products C1CC(NC(=O)C=2C(=CC(N)=C(Cl)C=2)OC)C(OC)CN1CCCOC1=CC=C(F)C=C1 DCSUBABJRXZOMT-UHFFFAOYSA-N 0.000 description 1
238000003776 cleavage reaction Methods 0.000 description 1
238000000576 coating method Methods 0.000 description 1
150000001875 compounds Chemical class 0.000 description 1
239000000470 constituent Substances 0.000 description 1
238000007796 conventional method Methods 0.000 description 1
238000001816 cooling Methods 0.000 description 1
239000006184 cosolvent Substances 0.000 description 1
229940097362 cyclodextrins Drugs 0.000 description 1
KWGRBVOPPLSCSI-UHFFFAOYSA-N d-ephedrine Natural products CNC(C)C(O)C1=CC=CC=C1 KWGRBVOPPLSCSI-UHFFFAOYSA-N 0.000 description 1
230000001419 dependent effect Effects 0.000 description 1
229960001985 dextromethorphan Drugs 0.000 description 1
235000014113 dietary fatty acids Nutrition 0.000 description 1
239000003085 diluting agent Substances 0.000 description 1
AMTWCFIAVKBGOD-UHFFFAOYSA-N dioxosilane;methoxy-dimethyl-trimethylsilyloxysilane Chemical compound O=[Si]=O.CO[Si](C)(C)O[Si](C)(C)C AMTWCFIAVKBGOD-UHFFFAOYSA-N 0.000 description 1
FGXWKSZFVQUSTL-UHFFFAOYSA-N domperidone Chemical compound C12=CC=CC=C2NC(=O)N1CCCN(CC1)CCC1N1C2=CC=C(Cl)C=C2NC1=O FGXWKSZFVQUSTL-UHFFFAOYSA-N 0.000 description 1
229960001253 domperidone Drugs 0.000 description 1
229940088679 drug related substance Drugs 0.000 description 1
238000001035 drying Methods 0.000 description 1
239000000839 emulsion Substances 0.000 description 1
238000005516 engineering process Methods 0.000 description 1
230000007613 environmental effect Effects 0.000 description 1
239000000194 fatty acid Substances 0.000 description 1
229930195729 fatty acid Natural products 0.000 description 1
150000004665 fatty acids Chemical class 0.000 description 1
239000003337 fertilizer Substances 0.000 description 1
238000009472 formulation Methods 0.000 description 1
239000007789 gas Substances 0.000 description 1
125000005456 glyceride group Chemical group 0.000 description 1
CPBQJMYROZQQJC-UHFFFAOYSA-N helium neon Chemical compound [He].[Ne] CPBQJMYROZQQJC-UHFFFAOYSA-N 0.000 description 1
229960001680 ibuprofen Drugs 0.000 description 1
238000007373 indentation Methods 0.000 description 1
239000002917 insecticide Substances 0.000 description 1
229960003136 leucine Drugs 0.000 description 1
239000012669 liquid formulation Substances 0.000 description 1
238000011068 loading method Methods 0.000 description 1
230000003232 mucoadhesive effect Effects 0.000 description 1
229920005615 natural polymer Polymers 0.000 description 1
235000016709 nutrition Nutrition 0.000 description 1
239000006186 oral dosage form Substances 0.000 description 1
229960005489 paracetamol Drugs 0.000 description 1
239000002245 particle Substances 0.000 description 1
239000006187 pill Substances 0.000 description 1
229920000573 polyethylene Polymers 0.000 description 1
229920001296 polysiloxane Polymers 0.000 description 1
229920001343 polytetrafluoroethylene Polymers 0.000 description 1
239000004810 polytetrafluoroethylene Substances 0.000 description 1
238000007639 printing Methods 0.000 description 1
KWGRBVOPPLSCSI-WCBMZHEXSA-N pseudoephedrine Chemical compound CN[C@@H](C)[C@@H](O)C1=CC=CC=C1 KWGRBVOPPLSCSI-WCBMZHEXSA-N 0.000 description 1
229960003908 pseudoephedrine Drugs 0.000 description 1
238000005057 refrigeration Methods 0.000 description 1
230000001105 regulatory effect Effects 0.000 description 1
RAPZEAPATHNIPO-UHFFFAOYSA-N risperidone Chemical compound FC1=CC=C2C(C3CCN(CC3)CCC=3C(=O)N4CCCCC4=NC=3C)=NOC2=C1 RAPZEAPATHNIPO-UHFFFAOYSA-N 0.000 description 1
229960001534 risperidone Drugs 0.000 description 1
150000003839 salts Chemical class 0.000 description 1
230000007017 scission Effects 0.000 description 1
229940083037 simethicone Drugs 0.000 description 1
239000011343 solid material Substances 0.000 description 1
238000007711 solidification Methods 0.000 description 1
230000008023 solidification Effects 0.000 description 1
239000000243 solution Substances 0.000 description 1
229910001220 stainless steel Inorganic materials 0.000 description 1
239000010935 stainless steel Substances 0.000 description 1
238000009955 starching Methods 0.000 description 1
238000003860 storage Methods 0.000 description 1
238000005092 sublimation method Methods 0.000 description 1
239000000454 talc Substances 0.000 description 1
229910052623 talc Inorganic materials 0.000 description 1
239000003760 tallow Substances 0.000 description 1
238000003856 thermoforming Methods 0.000 description 1
239000012815 thermoplastic material Substances 0.000 description 1
150000003626 triacylglycerols Chemical class 0.000 description 1
210000002700 urine Anatomy 0.000 description 1
238000009834 vaporization Methods 0.000 description 1
238000009736 wetting Methods 0.000 description 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2095—Tabletting processes; Dosage units made by direct compression of powders or specially processed granules, by eliminating solvents, by melt-extrusion, by injection molding, by 3D printing
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms

Landscapes

Health & Medical Sciences (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Pharmacology & Pharmacy (AREA)
Epidemiology (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Medicinal Preparation (AREA)
Medicines Containing Plant Substances (AREA)
Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Thermal Transfer Or Thermal Recording In General (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Medical Preparation Storing Or Oral Administration Devices (AREA)

NO19985877A 1996-06-17 1998-12-15 Fremgangsmate for a merke overflaten av faste raskt opplosende doseringsformer og faste raskt opplosende doseringsformer fremstilt ifolge fremgangsmaten NO321512B1 (no)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US2027496P	1996-06-17	1996-06-17
PCT/EP1997/003066 WO1997048384A2 (en)	1996-06-17	1997-06-10	Marking rapidly disintegrating dosage forms

Publications (3)

Publication Number	Publication Date
NO985877D0 NO985877D0 (no)	1998-12-15
NO985877L NO985877L (no)	1999-02-16
NO321512B1 true NO321512B1 (no)	2006-05-15

Family

ID=21797698

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
NO19985877A NO321512B1 (no)	1996-06-17	1998-12-15	Fremgangsmate for a merke overflaten av faste raskt opplosende doseringsformer og faste raskt opplosende doseringsformer fremstilt ifolge fremgangsmaten

Country Status (16)

Country	Link
EP (1)	EP0910346B1 (de)
JP (1)	JP2000512303A (de)
AT (1)	ATE261719T1 (de)
AU (1)	AU735071B2 (de)
BR (1)	BR9709907A (de)
CA (1)	CA2257305C (de)
DE (1)	DE69728147T2 (de)
DK (1)	DK0910346T3 (de)
ES (1)	ES2218686T3 (de)
IL (1)	IL127604A (de)
NO (1)	NO321512B1 (de)
NZ (1)	NZ332831A (de)
PT (1)	PT910346E (de)
TW (1)	TW466179B (de)
WO (1)	WO1997048384A2 (de)
ZA (1)	ZA975279B (de)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB9929843D0 (en)	1999-12-16	2000-02-09	Unilever Plc	Process for preparing granular detergent compositions
CA2392486A1 (en) *	2002-07-05	2002-12-08	Duchesnay Inc.	Pharmaceutical dosage form bearing pregnancy-friendly indicia
CA103771S (en)	2003-07-22	2006-01-18	Duchesnay Inc	Pharmaceutical dosage form
TWI547431B (zh) *	2004-06-09	2016-09-01	史密斯克萊美占公司	生產藥物之裝置及方法
US20060104910A1 (en) *	2004-11-15	2006-05-18	Keith Lerner	Over dosage indicating medicated film strip
NZ563459A (en) *	2005-05-26	2010-08-27	Eisai R&D Man Co Ltd	A method of marking a composition for use in oral administration
WO2009025371A1 (ja)	2007-08-22	2009-02-26	Astellas Pharma Inc.	錠剤印刷装置及び錠剤製造方法並びに錠剤
JP6027800B2 (ja) *	2011-07-15	2016-11-16	沢井製薬株式会社	素錠のマーキング方法
JP5916091B2 (ja) *	2012-01-31	2016-05-11	大原薬品工業株式会社	口腔内崩壊錠のｕｖレーザー印刷方法
CN104487094B (zh)	2012-07-20	2017-05-17	大塚制药株式会社	表面具有干燥油墨被膜的片剂、及用于喷墨打印机的油墨
CN103009825B (zh) *	2012-11-23	2015-12-16	新昌县捷奥激光制品有限公司	胶囊检测激光打标一体机
CN102975494B (zh) *	2012-11-23	2015-05-20	新昌县捷奥激光制品有限公司	一种胶囊激光打标机

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4548825A (en) *	1978-11-15	1985-10-22	Boehringer Ingelheim Gmbh	Method for ink-jet printing on uncoated tablets or uncoated tablet cores
JPS615988A (ja) *	1984-06-20	1986-01-11	Toshiba Corp	マ−キング方法
CH660750A5 (en) *	1984-11-06	1987-06-15	Thomae Gmbh Dr K	Physiologically acceptable inks for printing mouldings having a porous surface by inkjet writing means
JPH04122688A (ja) *	1990-09-13	1992-04-23	Takeda Chem Ind Ltd	錠剤及びカプセルのマーキング方法
IL105553A (en) *	1992-05-06	1998-01-04	Janssen Pharmaceutica Inc	Solid dosage form comprising a porous network of matrix forming material which disperses rapidly in water
US5457895A (en) *	1993-10-01	1995-10-17	R. P. Scherer Corporation	Method of identifying freeze-dried dosage forms

1997
- 1997-06-10 CA CA002257305A patent/CA2257305C/en not_active Expired - Lifetime
- 1997-06-10 BR BR9709907A patent/BR9709907A/pt not_active Application Discontinuation
- 1997-06-10 JP JP10502219A patent/JP2000512303A/ja active Pending
- 1997-06-10 IL IL12760497A patent/IL127604A/xx not_active IP Right Cessation
- 1997-06-10 AU AU32578/97A patent/AU735071B2/en not_active Expired
- 1997-06-10 DE DE69728147T patent/DE69728147T2/de not_active Expired - Lifetime
- 1997-06-10 WO PCT/EP1997/003066 patent/WO1997048384A2/en active IP Right Grant
- 1997-06-10 AT AT97928185T patent/ATE261719T1/de active
- 1997-06-10 NZ NZ332831A patent/NZ332831A/en not_active IP Right Cessation
- 1997-06-10 PT PT97928185T patent/PT910346E/pt unknown
- 1997-06-10 DK DK97928185T patent/DK0910346T3/da active
- 1997-06-10 ES ES97928185T patent/ES2218686T3/es not_active Expired - Lifetime
- 1997-06-10 EP EP97928185A patent/EP0910346B1/de not_active Expired - Lifetime
- 1997-06-13 ZA ZA975279A patent/ZA975279B/xx unknown
- 1997-06-16 TW TW086108286A patent/TW466179B/zh not_active IP Right Cessation
1998
- 1998-12-15 NO NO19985877A patent/NO321512B1/no not_active IP Right Cessation

Also Published As

Publication number	Publication date
NZ332831A (en)	1999-10-28
EP0910346A2 (de)	1999-04-28
IL127604A (en)	2003-05-29
DE69728147T2 (de)	2004-10-28
WO1997048384A3 (en)	1998-02-05
HK1018001A1 (en)	1999-12-10
PT910346E (pt)	2004-07-30
DK0910346T3 (da)	2004-07-12
IL127604A0 (en)	1999-10-28
BR9709907A (pt)	1999-08-10
AU3257897A (en)	1998-01-07
ATE261719T1 (de)	2004-04-15
NO985877D0 (no)	1998-12-15
AU735071B2 (en)	2001-06-28
NO985877L (no)	1999-02-16
WO1997048384A2 (en)	1997-12-24
ES2218686T3 (es)	2004-11-16
DE69728147D1 (de)	2004-04-22
ZA975279B (en)	1998-12-14
CA2257305C (en)	2006-04-04
TW466179B (en)	2001-12-01
CA2257305A1 (en)	1997-12-24
EP0910346B1 (de)	2004-03-17
JP2000512303A (ja)	2000-09-19

Publication	Publication Date	Title
US5330763A (en)	1994-07-19	Delivery matrices prepared by solid-state dissolution
US5558880A (en)	1996-09-24	Pharmaceutical and other dosage forms
CA2257303C (en)	2006-04-04	Biconvex rapidly disintegrating dosage forms
US6906043B2 (en)	2005-06-14	Rapidly soluble film preparation
CA2135062C (en)	1999-05-25	Pharmaceutical and other dosage forms
EP0910346B1 (de)	2004-03-17	Markieren von schnell zerfallenden dosierungsformen
KR100782897B1 (ko)	2008-04-08	급속붕괴제형의표시방법
HK1018001B (en)	2004-08-27	Marking rapidly disintegrating dosage forms
MXPA98010823A (en)	1999-04-27	Marking of dosed forms of rapida desintegrac
AU677198C (en)	1997-12-04	Pharmaceutical and other dosage forms
MXPA98010822A (en)	1999-04-27	Biconvexas forms of dosage that disappear rapidame
HK1019200B (en)	2002-05-24	Biconvex rapidly disintegrating dosage forms
IE904520A1 (en)	1991-07-03	Preparation of pharmaceutical and other matrix systems by¹solid-state dissolution

Legal Events

Date	Code	Title	Description
2017-07-10	MK1K	Patent expired